Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-07 1:20 pm Purchase | 2025-06-30 | 13G | AbbVie Inc. ABBV | The Vanguard Group | 177,266,703 10.030% | 16,886,646 (+10.53%) | Filing History |
| 2025-02-18 4:15 pm Purchase | 2025-02-11 | 13G | Xilio Therapeutics, Inc. XLO | AbbVie Inc. ABBV | 4,347,826 9.000% | 4,347,826 (New Position) | Filing History |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | AbbVie Inc. ABBV | The Vanguard Group | 160,380,057 9.080% | 2,062,505 (+1.30%) | Filing History |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | AbbVie Inc. ABBV | BlackRock Inc. BLK | 143,180,060 8.100% | 4,477,302 (+3.23%) | Filing History |
| 2023-02-15 5:45 pm Purchase | 2022-12-31 | 13G | AbbVie Inc. ABBV | BlackRock Inc. BLK | 138,702,758 7.800% | 10,505,203 (+8.19%) | Filing History |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | AbbVie Inc. ABBV | The Vanguard Group | 158,317,552 8.950% | 12,005,483 (+8.21%) | Filing History |
| 2022-02-09 3:15 pm Purchase | 2021-12-31 | 13G | AbbVie Inc. ABBV | The Vanguard Group | 146,312,069 8.280% | 3,748,995 (+2.63%) | Filing History |
| 2022-02-03 4:29 pm Purchase | 2021-12-31 | 13G | AbbVie Inc. ABBV | BlackRock Inc. BLK | 128,197,555 7.300% | 3,774,071 (+3.03%) | Filing History |